Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on July 24, 2007
JNCI Journal of the National Cancer Institute 2007 99(15):1210-1211; doi:10.1093/jnci/djm052
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/15/1210-a    most recent
djm052v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Van Schil, P.
Right arrow Articles by Van Meerbeeck, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Van Schil, P.
Right arrow Articles by Van Meerbeeck, J.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Response: Re: Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

P. Van Schil, J. Van Meerbeeck

Affiliations of authors: Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Antwerp, Belgium (PVS); Department of Pulmonary Medicine, University Hospital of Ghent, Gent, Belgium (JVM)

Correspondence to: J. Van Meerbeeck, MD, PhD, Department of Pulmonary Medicine, University Hospital of Ghent, De Pintelaan 185, B-9000 Gent, Belgium (e-mail: jan.vanmeerbeeck@ugent.be).

The first 10% of the full text of this article appears below.

We would first like to thank the authors for their nice comments about our European Organisation for Research and Treatment of Cancer (EORTC) 08941 trial.

Regarding their first remark, the purpose of the EORTC 08941 study was to explore whether patients with proven, initially considered unresectable stage IIIA-N2 non–small-cell lung cancer (NSCLC) who responded to induction chemotherapy had a better prognosis after surgical resection than with radiotherapy. Unresectability was determined by the local . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer
Francesco Leo, Tommaso De Pas, Gianpiero Catalano, Gaia Piperno, Giuseppe Curigliano, Piergiorgio Solli, Giulia Veronesi, Francesco Petrella, and Lorenzo Spaggiari
J Natl Cancer Inst 2007 99: 1210. [Extract] [Full Text] [PDF]